Development and validation of an improved liquid chromatography-mass spectrometry method for the determination of pemetrexed in human plasma

J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Aug 15;877(24):2451-6. doi: 10.1016/j.jchromb.2009.06.020. Epub 2009 Jun 21.

Abstract

An improved liquid chromatography-mass spectrometry method for the determination of pemetrexed in human plasma was developed and validated using a simple quadrupole LC-MS and a new SPE cartridge (Plexa Bond Elut). The analysis was achieved with a C18 analytical column using a mobile phase consisting of formic acid/acetonitrile and isocratic flow for 7 min. The linear ranges (r(2)>0.99) were found from 5 to 5000 ng/mL. The lower limit of detection was 2.5 ng/mL. Within-day and between-day precisions were less than 7.2% and inaccuracy did not exceed 2.8%. This new method is suitable to support pharmacokinetic studies and drug monitoring.

Publication types

  • Evaluation Study
  • Validation Study

MeSH terms

  • Antineoplastic Agents / blood*
  • Chromatography, Liquid / methods*
  • Drug Monitoring / methods
  • Glutamates / blood*
  • Guanine / analogs & derivatives*
  • Guanine / blood
  • Humans
  • Mass Spectrometry / methods*
  • Pemetrexed
  • Sensitivity and Specificity

Substances

  • Antineoplastic Agents
  • Glutamates
  • Pemetrexed
  • Guanine